Inventor
TYNER JOAN D
US31 patents
⚠️ This page may combine multiple inventors who share the name “TYNER JOAN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
24 patentsUS5593896AJan 14, 1997
Reagents and methods for the detection and quantification of thyroxine in fluid samples
ABBOTT LAB157 citations98
US5359093AOct 25, 1994
Reagents and methods for the detection and quantification of thyroxine in fluid samples
ABBOTT LAB152 citations98
US6818392B2Nov 16, 2004
Monoclonal antibodies to human immunodeficiency virus and uses thereof
ABBOTT LAB44 citations95
US8030026B2Oct 4, 2011
Antibodies to troponin I and methods of use thereof
ABBOTT LAB19 citations91
US6329157B1Dec 11, 2001
Antigen cocktails and uses thereof
ABBOTT LAB17 citations89
US5753430AMay 19, 1998
Monoclonal antibodies to hepatitis C virus and method for using same
ABBOTT LAB29 citations88
US7858752B2Dec 28, 2010
Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
ABBOTT LAB12 citations81
US5691456ANov 25, 1997
Reagents and methods for the detection and quantification of thyroxine in fluid samples
ABBOTT LAB14 citations81
US7731965B2Jun 8, 2010
Human ring specific BNP antibodies
ABBOTT LAB10 citations80
US8022188B2Sep 20, 2011
Immunosuppressant binding antibodies and methods of obtaining and using same
ABBOTT LAB7 citations77
US6221619B1Apr 24, 2001
Method of using P35 antigen of toxoplasma gondii in distinguishing acute from chronic toxoplasmosis
ABBOTT LAB13 citations67
US9115189B2Aug 25, 2015
Monoclonal antibodies to human immunodeficiency virus and uses thereof
ABBOTT LAB1 citations61
US7531639B2May 12, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
ABBOTT LAB2 citations61
US7531642B2May 12, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26).
ABBOTT LAB1 citations61
US7531640B2May 12, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
ABBOTT LAB2 citations61
US7998480B2Aug 16, 2011
Human BNP immunospecific antibodies
ABBOTT LAB4 citations58
US10215754B2Feb 26, 2019
Anti-T. cruzi antibodies and methods of use
ABBOTT LAB0 citations51
US9482667B2Nov 1, 2016
Anti-T. cruzi antibodies and methods of use
ABBOTT LAB0 citations51
US7939069B2May 10, 2011
Human BNP immunospecific antibodies
ABBOTT LAB1 citations51
US7897332B2Mar 1, 2011
Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins
ABBOTT LAB0 citations51
US7531641B2May 12, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
ABBOTT LAB0 citations51
US7531638B2May 12, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
ABBOTT LAB0 citations51
US7528238B2May 5, 2009
Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
ABBOTT LAB0 citations51
US5648272AJul 15, 1997
Reagents and methods for the detection and quantification of thyroxine in fluid samples
ABBOTT LAB1 citations51